Predictive Value of <sup>18</sup>F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer

We investigated predictions from <sup>18</sup>F-FDG PET/CT using machine learning (ML) to assess the neoadjuvant CCRT response of patients with stage III non-small cell lung cancer (NSCLC) and compared them with predictions from conventional PET parameters and from physicians. A retrospe...

Full description

Bibliographic Details
Main Authors: Jang Yoo, Jaeho Lee, Miju Cheon, Sang-Keun Woo, Myung-Ju Ahn, Hong Ryull Pyo, Yong Soo Choi, Joung Ho Han, Joon Young Choi
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/8/1987
_version_ 1797436472964415488
author Jang Yoo
Jaeho Lee
Miju Cheon
Sang-Keun Woo
Myung-Ju Ahn
Hong Ryull Pyo
Yong Soo Choi
Joung Ho Han
Joon Young Choi
author_facet Jang Yoo
Jaeho Lee
Miju Cheon
Sang-Keun Woo
Myung-Ju Ahn
Hong Ryull Pyo
Yong Soo Choi
Joung Ho Han
Joon Young Choi
author_sort Jang Yoo
collection DOAJ
description We investigated predictions from <sup>18</sup>F-FDG PET/CT using machine learning (ML) to assess the neoadjuvant CCRT response of patients with stage III non-small cell lung cancer (NSCLC) and compared them with predictions from conventional PET parameters and from physicians. A retrospective study was conducted of 430 patients. They underwent <sup>18</sup>F-FDG PET/CT before initial treatment and after neoadjuvant CCRT followed by curative surgery. We analyzed texture features from segmented tumors and reviewed the pathologic response. The ML model employed a random forest and was used to classify the binary outcome of the pathological complete response (pCR). The predictive accuracy of the ML model for the pCR was 93.4%. The accuracy of predicting pCR using the conventional PET parameters was up to 70.9%, and the accuracy of the physicians’ assessment was 80.5%. The accuracy of the prediction from the ML model was significantly higher than those derived from conventional PET parameters and provided by physicians (<i>p</i> < 0.05). The ML model is useful for predicting pCR after neoadjuvant CCRT, which showed a higher predictive accuracy than those achieved from conventional PET parameters and from physicians.
first_indexed 2024-03-09T11:03:14Z
format Article
id doaj.art-551b455b2cde4c48b3f00722c2d7fba6
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T11:03:14Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-551b455b2cde4c48b3f00722c2d7fba62023-12-01T01:07:49ZengMDPI AGCancers2072-66942022-04-01148198710.3390/cancers14081987Predictive Value of <sup>18</sup>F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung CancerJang Yoo0Jaeho Lee1Miju Cheon2Sang-Keun Woo3Myung-Ju Ahn4Hong Ryull Pyo5Yong Soo Choi6Joung Ho Han7Joon Young Choi8Department of Nuclear Medicine, Veterans Health Service Medical Center, Seoul 05368, KoreaDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, KoreaDepartment of Nuclear Medicine, Veterans Health Service Medical Center, Seoul 05368, KoreaDepartment of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul 01812, KoreaDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaWe investigated predictions from <sup>18</sup>F-FDG PET/CT using machine learning (ML) to assess the neoadjuvant CCRT response of patients with stage III non-small cell lung cancer (NSCLC) and compared them with predictions from conventional PET parameters and from physicians. A retrospective study was conducted of 430 patients. They underwent <sup>18</sup>F-FDG PET/CT before initial treatment and after neoadjuvant CCRT followed by curative surgery. We analyzed texture features from segmented tumors and reviewed the pathologic response. The ML model employed a random forest and was used to classify the binary outcome of the pathological complete response (pCR). The predictive accuracy of the ML model for the pCR was 93.4%. The accuracy of predicting pCR using the conventional PET parameters was up to 70.9%, and the accuracy of the physicians’ assessment was 80.5%. The accuracy of the prediction from the ML model was significantly higher than those derived from conventional PET parameters and provided by physicians (<i>p</i> < 0.05). The ML model is useful for predicting pCR after neoadjuvant CCRT, which showed a higher predictive accuracy than those achieved from conventional PET parameters and from physicians.https://www.mdpi.com/2072-6694/14/8/1987non-small cell lung cancerneoadjuvant concurrent chemoradiotherapy<sup>18</sup>F-FDG PET/CTmachine learningrandom forestpathologic complete response
spellingShingle Jang Yoo
Jaeho Lee
Miju Cheon
Sang-Keun Woo
Myung-Ju Ahn
Hong Ryull Pyo
Yong Soo Choi
Joung Ho Han
Joon Young Choi
Predictive Value of <sup>18</sup>F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer
Cancers
non-small cell lung cancer
neoadjuvant concurrent chemoradiotherapy
<sup>18</sup>F-FDG PET/CT
machine learning
random forest
pathologic complete response
title Predictive Value of <sup>18</sup>F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer
title_full Predictive Value of <sup>18</sup>F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer
title_fullStr Predictive Value of <sup>18</sup>F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer
title_full_unstemmed Predictive Value of <sup>18</sup>F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer
title_short Predictive Value of <sup>18</sup>F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer
title_sort predictive value of sup 18 sup f fdg pet ct using machine learning for pathological response to neoadjuvant concurrent chemoradiotherapy in patients with stage iii non small cell lung cancer
topic non-small cell lung cancer
neoadjuvant concurrent chemoradiotherapy
<sup>18</sup>F-FDG PET/CT
machine learning
random forest
pathologic complete response
url https://www.mdpi.com/2072-6694/14/8/1987
work_keys_str_mv AT jangyoo predictivevalueofsup18supffdgpetctusingmachinelearningforpathologicalresponsetoneoadjuvantconcurrentchemoradiotherapyinpatientswithstageiiinonsmallcelllungcancer
AT jaeholee predictivevalueofsup18supffdgpetctusingmachinelearningforpathologicalresponsetoneoadjuvantconcurrentchemoradiotherapyinpatientswithstageiiinonsmallcelllungcancer
AT mijucheon predictivevalueofsup18supffdgpetctusingmachinelearningforpathologicalresponsetoneoadjuvantconcurrentchemoradiotherapyinpatientswithstageiiinonsmallcelllungcancer
AT sangkeunwoo predictivevalueofsup18supffdgpetctusingmachinelearningforpathologicalresponsetoneoadjuvantconcurrentchemoradiotherapyinpatientswithstageiiinonsmallcelllungcancer
AT myungjuahn predictivevalueofsup18supffdgpetctusingmachinelearningforpathologicalresponsetoneoadjuvantconcurrentchemoradiotherapyinpatientswithstageiiinonsmallcelllungcancer
AT hongryullpyo predictivevalueofsup18supffdgpetctusingmachinelearningforpathologicalresponsetoneoadjuvantconcurrentchemoradiotherapyinpatientswithstageiiinonsmallcelllungcancer
AT yongsoochoi predictivevalueofsup18supffdgpetctusingmachinelearningforpathologicalresponsetoneoadjuvantconcurrentchemoradiotherapyinpatientswithstageiiinonsmallcelllungcancer
AT jounghohan predictivevalueofsup18supffdgpetctusingmachinelearningforpathologicalresponsetoneoadjuvantconcurrentchemoradiotherapyinpatientswithstageiiinonsmallcelllungcancer
AT joonyoungchoi predictivevalueofsup18supffdgpetctusingmachinelearningforpathologicalresponsetoneoadjuvantconcurrentchemoradiotherapyinpatientswithstageiiinonsmallcelllungcancer